Short answer
Organon & Co (OGN) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Merger agreement with Sun Pharma approved, clearing the key shareholder vote for Organon’s acquisition.
Organon & Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Merger agreement with Sun Pharma approved, clearing the key shareholder vote for Organon’s acquisition
- 192,776,552 votes for versus 2,573,118 against, representing strong approval among votes cast
- 74.51% of voting power represented, exceeding the quorum requirement for the special meeting
- Merger-related executive compensation approved on a non-binding basis, 185,141,986 votes for versus 9,553,830 against
- Organon expected to become a wholly owned subsidiary of Sun Pharma USA upon merger completion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Organon & Co 8-K filings
Get the next OGN 8-K as it lands
Follow OGN for push alerts, or ask the research agent what this filing means.